These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 22427929)

  • 1. CXCL12 mediates trophic interactions between endothelial and tumor cells in glioblastoma.
    Rao S; Sengupta R; Choe EJ; Woerner BM; Jackson E; Sun T; Leonard J; Piwnica-Worms D; Rubin JB
    PLoS One; 2012; 7(3):e33005. PubMed ID: 22427929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABCF1/CXCL12/CXCR4 Enhances Glioblastoma Cell Proliferation, Migration, and Invasion by Activating the PI3K/AKT Signal Pathway.
    Yin X; Xia K; Peng S; Tan B; Huang Y; Wang M; He M
    Dev Neurosci; 2024; 46(3):210-220. PubMed ID: 37757768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MMP-2 suppression abrogates irradiation-induced microtubule formation in endothelial cells by inhibiting αvβ3-mediated SDF-1/CXCR4 signaling.
    Maddirela DR; Kesanakurti D; Gujrati M; Rao JS
    Int J Oncol; 2013 Apr; 42(4):1279-88. PubMed ID: 23381805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and functional heterogeneity of chemokine receptors CXCR4 and CXCR7 in primary patient-derived glioblastoma cells.
    Liu C; Pham K; Luo D; Reynolds BA; Hothi P; Foltz G; Harrison JK
    PLoS One; 2013; 8(3):e59750. PubMed ID: 23555768
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of CXCL12/CXCR4 autocrine/paracrine loop reduces viability of human glioblastoma stem-like cells affecting self-renewal activity.
    Gatti M; Pattarozzi A; Bajetto A; Würth R; Daga A; Fiaschi P; Zona G; Florio T; Barbieri F
    Toxicology; 2013 Dec; 314(2-3):209-20. PubMed ID: 24157575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemokine CXCL12 activates dual CXCR4 and CXCR7-mediated signaling pathways in pancreatic cancer cells.
    Heinrich EL; Lee W; Lu J; Lowy AM; Kim J
    J Transl Med; 2012 Apr; 10():68. PubMed ID: 22472349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory CXCL12-CXCR4/CXCR7 axis mediates G-protein signaling pathway to influence the invasion and migration of nasopharyngeal carcinoma cells.
    Qiao N; Wang L; Wang T; Li H
    Tumour Biol; 2016 Jun; 37(6):8169-79. PubMed ID: 26715277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemokine receptor CXCR7 is a functional receptor for CXCL12 in brain endothelial cells.
    Liu Y; Carson-Walter E; Walter KA
    PLoS One; 2014; 9(8):e103938. PubMed ID: 25084358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence of glioblastoma after radio-chemotherapy is associated with an angiogenic switch to the CXCL12-CXCR4 pathway.
    Tabouret E; Tchoghandjian A; Denicolai E; Delfino C; Metellus P; Graillon T; Boucard C; Nanni I; Padovani L; Ouafik L; Figarella-Branger D; Chinot O
    Oncotarget; 2015 May; 6(13):11664-75. PubMed ID: 25860928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Notch1 signaling pathway promotes invasion, self-renewal and growth of glioma initiating cells via modulating chemokine system CXCL12/CXCR4.
    Yi L; Zhou X; Li T; Liu P; Hai L; Tong L; Ma H; Tao Z; Xie Y; Zhang C; Yu S; Yang X
    J Exp Clin Cancer Res; 2019 Aug; 38(1):339. PubMed ID: 31382985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CXCL12-induced upregulation of FOXM1 expression promotes human glioblastoma cell invasion.
    Wang S; Zhang S; Li J; Xu X; Weng Y; Zheng M; Ouyang L; Li F
    Biochem Biophys Res Commun; 2014 Apr; 447(1):1-6. PubMed ID: 24561124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adult mouse subventricular zones stimulate glioblastoma stem cells specific invasion through CXCL12/CXCR4 signaling.
    Goffart N; Kroonen J; Di Valentin E; Dedobbeleer M; Denne A; Martinive P; Rogister B
    Neuro Oncol; 2015 Jan; 17(1):81-94. PubMed ID: 25085362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenic effects of stromal cell-derived factor-1 (SDF-1/CXCL12) variants in vitro and the in vivo expressions of CXCL12 variants and CXCR4 in human critical leg ischemia.
    Ho TK; Tsui J; Xu S; Leoni P; Abraham DJ; Baker DM
    J Vasc Surg; 2010 Mar; 51(3):689-99. PubMed ID: 20206813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CXCL12 secreted from glioma stem cells regulates their proliferation.
    Uemae Y; Ishikawa E; Osuka S; Matsuda M; Sakamoto N; Takano S; Nakai K; Yamamoto T; Matsumura A
    J Neurooncol; 2014 Mar; 117(1):43-51. PubMed ID: 24442483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting CXCR4 by a selective peptide antagonist modulates tumor microenvironment and microglia reactivity in a human glioblastoma model.
    Mercurio L; Ajmone-Cat MA; Cecchetti S; Ricci A; Bozzuto G; Molinari A; Manni I; Pollo B; Scala S; Carpinelli G; Minghetti L
    J Exp Clin Cancer Res; 2016 Mar; 35():55. PubMed ID: 27015814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCR4 increases in-vivo glioma perivascular invasion, and reduces radiation induced apoptosis: A genetic knockdown study.
    Yadav VN; Zamler D; Baker GJ; Kadiyala P; Erdreich-Epstein A; DeCarvalho AC; Mikkelsen T; Castro MG; Lowenstein PR
    Oncotarget; 2016 Dec; 7(50):83701-83719. PubMed ID: 27863376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCL12/CXCR4 promotes motility and proliferation of glioma cells.
    do Carmo A; Patricio I; Cruz MT; Carvalheiro H; Oliveira CR; Lopes MC
    Cancer Biol Ther; 2010 Jan; 9(1):56-65. PubMed ID: 19923906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regorafenib Reverses Temozolomide-Induced CXCL12/CXCR4 Signaling and Triggers Apoptosis Mechanism in Glioblastoma.
    Chiang IT; Liu YC; Liu HS; Ali AAA; Chou SY; Hsu TI; Hsu FT
    Neurotherapeutics; 2022 Mar; 19(2):616-634. PubMed ID: 35267171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive characterization of the prostate tumor microenvironment identifies CXCR4/CXCL12 crosstalk as a novel antiangiogenic therapeutic target in prostate cancer.
    Heidegger I; Fotakis G; Offermann A; Goveia J; Daum S; Salcher S; Noureen A; Timmer-Bosscha H; Schäfer G; Walenkamp A; Perner S; Beatovic A; Moisse M; Plattner C; Krogsdam A; Haybaeck J; Sopper S; Thaler S; Keller MA; Klocker H; Trajanoski Z; Wolf D; Pircher A
    Mol Cancer; 2022 Jun; 21(1):132. PubMed ID: 35717322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamoxifen as a modulator of CXCL12-CXCR4-CXCR7 chemokine axis: A breast cancer and glioblastoma view.
    Gonçalves TL; de Araújo LP; Pereira Ferrer V
    Cytokine; 2023 Oct; 170():156344. PubMed ID: 37639844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.